1 Programs

  • Optimal Use of PARP Inhibitors for Patients with Hormone-Sensitive and Castration-Resistant Metastatic Prostate Cancer

    Explore program
    • April 2026 1.25 ABIM MOC, ABS MOC, CME 51min
      • W
      Wassim Abida
    • April 2026 0.75 ABIM MOC, ABS MOC, CME 27min
      • W
      Wassim Abida